Biblio
Found 56 results
Author Keyword Title Type [ Year
Filters: Keyword is Genetic Predisposition to Disease [Clear All Filters]
Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.
.
2004. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.
.
2004. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.. Nature. 429(6987):75-9.
.
2004. Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.. Mol Psychiatry. 9(11):1042-51.
.
2004. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder.. Am J Med Genet B Neuropsychiatr Genet. 139B(1):51-3.
.
2005. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.. Hum Mol Genet. 14(3):447-60.
.
2005. Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.. J Med Genet. 42(10):787-92.
.
2005. Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease.. Neurosci Lett. 381(1-2):36-41.
.
2005. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.. Neurobiol Aging. 27(8):1087-93.
.
2006. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.. Neuron. 54(5):713-20.
.
2007. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.. Arch Neurol. 65(11):1518-26.
.
2008. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.. Am J Hum Genet. 83(5):623-32.
.
2008. The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease.. Curr Neurol Neurosci Rep. 8(5):384-91.
.
2008. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.. Nat Genet. 41(2):192-8.
.
2009. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.. Nat Genet. 41(10):1088-93.
.
2009. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.. Am J Hum Genet. 84(1):35-43.
.
2009. Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.. Hum Mol Genet. 19(10):2068-78.
.
2010. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. Hum Mol Genet. 19(16):3295-301.
.
2010. Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.. Neurogenetics. 11(3):335-48.
.
2010. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.. Nat Genet. 43(5):429-35.
.
2011. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
.
2011. A comprehensive genetic association study of Alzheimer disease in African Americans.. Arch Neurol. 68(12):1569-79.
.
2011. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.. Nat Genet. 43(7):699-705.
.
2011. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.. PLoS Genet. 8(6):e1002707.
.
2012. Genome-wide association analysis of age-at-onset in Alzheimer's disease.. Mol Psychiatry. 17(12):1340-6.
.
2012.